Filing Details
- Accession Number:
- 0001209191-20-007525
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-07 16:28:47
- Reporting Period:
- 2020-02-05
- Accepted Time:
- 2020-02-07 16:28:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789815 | Ourania Tatsis | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp, Cro | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-05 | 3,500 | $0.00 | 10,752 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2020-02-05 | 6,194 | $0.00 | 16,946 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2020-02-06 | 559 | $187.53 | 17,505 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-06 | 408 | $155.57 | 17,913 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-06 | 571 | $238.77 | 17,342 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-06 | 240 | $239.68 | 17,102 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-06 | 90 | $240.70 | 17,012 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-06 | 66 | $242.47 | 16,946 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-06 | 559 | $0.00 | 559 | $187.53 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-06 | 408 | $0.00 | 408 | $155.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,704 | 2029-02-05 | No | 4 | M | Direct | |
| 3,261 | 2028-02-05 | No | 4 | M | Direct |
Footnotes
- Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 2/24/2020.
- Restricted stock unit award that vests in installments beginning on 02/10/2021.
- Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $238.77 (range $238.20 to $239.14).
- Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $239.68 (range $239.25 to $240.13).
- Open market sales reported on this line occurred at a weighted average price of $240.70 (range $240.47 to $241.04).
- The option vests in 16 quarterly installments from 02/06/2019.
- The option vests in 16 quarterly installments from 02/06/2018.
Billionaire Hedge Funds
